Samuel Wertheimer Ph.D Overview
- Company
- Poliwogg Regener...
- Primary Position
-
Executive Vice...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Samuel Wertheimer Ph.D General Information
Biography
Dr. Samuel Wertheimer served as Executive Vice President & Chairman at Poliwogg Regenerative Medicine Fund.
Contact Information
Address
- 733 Third avenue
- 15th Floor
- New York, NY 10017
- United States
Samuel Wertheimer Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Poliwogg Regenerative Medicine Fund | Company | Executive Vice President & Chairman | New York, NY | Asset Management |
Samuel Wertheimer Ph.D Board Seats (1)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Poliwogg Regenerative Medicine Fund | Asset Management | Privately Held (backing) | Corporate Backed or Acquired | New York, NY |
Samuel Wertheimer Ph.D Lead Partner on Deals (8)
Samuel Wertheimer Ph.D has been the lead partner on 8 deals. Their latest deal was with NeurAxon Pharma, a pharmaceuticals company. The deal was made for on 05-Mar-2010.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| NeurAxon Pharma | 05-Mar-2010 | Later Stage VC | Completed | Pharmaceuticals | Mississauga, Canada | |
| InteKrin | 11-Jan-2007 | Completed | Pharmaceuticals | Redwood City, CA | ||
| Biodel | 02-Aug-2006 | Completed | Pharmaceuticals | Danbury, CT | ||
| Corus Pharma | 13-Apr-2004 | Completed | Pharmaceuticals | Seattle, WA | ||
| Corus Pharma | 07-Mar-2003 | Completed | Pharmaceuticals | Seattle, WA | ||
| Corus Pharma | 21-Feb-2003 | Completed | Pharmaceuticals | Seattle, WA | ||
| Corus Pharma | 23-Sep-2002 | Early Stage VC | Completed | Pharmaceuticals | Seattle, WA | |
| Corus Pharma | 01-May-2001 | Early Stage VC (Series A) | Completed | Pharmaceuticals | Seattle, WA |
Samuel Wertheimer Ph.D Network (58)
Board Members (24)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| James Hauslein | Brookline Capital Acquisition | Self | New York, NY | |
| Elgar Peerschke | Brookline Capital Acquisition | Self | New York, NY | |
| Apexigen | Self | San Carlos, CA | ||
| Brookline Capital Acquisition | Self | New York, NY | ||
| Biodel | Self | Danbury, CT |
Portfolio Executives (21)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| John Andrews Ph.D | NeurAxon Pharma | Chief Executive Officer & Co-Founder | 05-Mar-2010 | Mississauga, Canada |
| Lawrence Bloch MD | NeurAxon Pharma | Chief Executive Officer | 05-Mar-2010 | Mississauga, Canada |
| InteKrin | Chief Medical Officer & Chief Scientific Officer | 11-Jan-2007 | Redwood City, CA | |
| InteKrin | Chief Executive Officer, Founder & President | 11-Jan-2007 | Redwood City, CA | |
| Biodel | Co-Founder | 02-Aug-2006 | Danbury, CT |
Fund Team Members (13)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| David Bonita MD | OrbiMed | OrbiMed Royalty Opportunities Fund | New York, NY |
| David Bonita MD | OrbiMed | OrbiMed Private Investments III | New York, NY |
| OrbiMed | New York, NY | ||
| OrbiMed | New York, NY | ||
| OrbiMed | New York, NY |
Samuel Wertheimer Ph.D Affiliated Funds (4)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Caduceus Private Investments | OrbiMed | Venture Capital - Later Stage | Closed | 2001 | ||||
| Caduceus Private Investments II | OrbiMed | Venture Capital - Later Stage | Fully Invested | 2004 | ||||
| OrbiMed Royalty Opportunities Fund | OrbiMed | Direct Lending | Closed | 2011 | ||||
| OrbiMed Private Investments III | OrbiMed | Venture Capital - Later Stage | Closed | 2007 |
Samuel Wertheimer Ph.D Advisory Roles (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Brookline Capital Markets | Service Provider | Senior Scientific Advisor | New York, NY | Investment Bank |
Samuel Wertheimer Ph.D FAQs
-
Who is Samuel Wertheimer Ph.D?
Dr. Samuel Wertheimer served as Executive Vice President & Chairman at Poliwogg Regenerative Medicine Fund.
-
How much does Samuel Wertheimer Ph.D typically invest?
Samuel Wertheimer Ph.D's median deal size is .
-
What is Samuel Wertheimer Ph.D’s main position?
Samuel Wertheimer Ph.D’s primary position is Executive Vice President & Chairman.
-
How many active board seats does Samuel Wertheimer Ph.D hold?
Samuel Wertheimer Ph.D holds a board seat in Poliwogg Regenerative Medicine Fund.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
